Related references
Note: Only part of the references are listed.A randomized controlled trial of thymalfasin plus transarterial chemoembolization for unresectable hepatocellular carcinoma
Robert G. Gish et al.
HEPATOLOGY INTERNATIONAL (2009)
Thymostimulin in advanced hepatocellular carcinoma: A phase II trial
Matthias M. Dollinger et al.
BMC CANCER (2008)
Design and endpoints of clinical trials in hepatocellular carcinoma
Josep M. Llovet et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Local/regional and systemic treatments of hepatocellular carcinoma
M Beaugrand et al.
SEMINARS IN LIVER DISEASE (2005)
Systemic treatment and liver transplantation for hepatocellular carcinoma: two ends of the therapeutic spectrum
A Burroughs et al.
LANCET ONCOLOGY (2004)
Primary liver cancer:: Worldwide incidence and trends
FX Bosch et al.
GASTROENTEROLOGY (2004)
Hepatocellular carcinoma: Primary and secondary prophylaxis as well as medical therapy
WE Fleig et al.
CHIRURGISCHE GASTROENTEROLOGIE (2003)
Measuring health-related quality of life in patients with hepatobiliary cancers: The functional assessment of cancer therapy-hepatobiliary questionnaire
N Heffernan et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Prognostic prediction and treatment strategy in hepatocellular carcinoma
J Bruix et al.
HEPATOLOGY (2002)
New guidelines to evaluate the response to treatment in solid tumors
F Duffaud et al.
BULLETIN DU CANCER (2000)
New guidelines to evaluate the response to treatment in solid Tumors
P Therasse et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Share Paper
